V.R. Atharvaveda Pharmaceuticals Private Limited, a active private limited company, was established on 28 January 2021 in Hathras, Uttar Pradesh, India. Engaging in ayurvedic products & services within the healthcare sector, it holds CIN: U24297UP2021PTC140940. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Formerly known as V.R. Mohta Ayurved Private Limited. It upholds a compliant status. Its leadership includes Vishesh Sharma (Director), Vimlesh Sharma (Director), Ajay Kumar Sharma (Managing Director). Past directors included Vishesh Sharma, Raj Kumar Sharma, Rajul Mohta. It holds ₹1.00 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.N., 01 Vivekanand Nagar Aligarh Road Hathras, Hathras, Uttar Pradesh, 204101.
U24297UP2021PTC140940
140940
28 January 2021
₹1.00 M
₹1.00 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into V.R. Atharvaveda Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vishesh Sharma | Director | 03 Jul 2021 | Current |
| Vimlesh Sharma | Director | 01 Jul 2024 | Current |
| Ajay Kumar Sharma | Managing Director | 01 Jul 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director Appointed In Casual Vacancy | 05 Feb 2022 | Past |
| Pramod Abcsdd | Director | 28 Jun 2021 | Past |
| Pramod Abcsdd | Director | 26 Jun 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
V.R. Atharvaveda Pharmaceuticals Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 298.45% increase in profit. The company's net worth Soared by an impressive increase of 35.15%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to V.R. Atharvaveda Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹10,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2024 | Canara Bank | ₹1.00 Cr | Open |
Explore comprehensive loan charge details -
V.R. Atharvaveda Pharmaceuticals has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of V.R. Atharvaveda Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped V.R. Atharvaveda Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity V.R. Atharvaveda Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
A charge with Canara Bank amounted to Rs. 10.00 M with Charge ID 100980581 was registered on 18 Sep 2024. was recorded as a recent event.
The activity Vimlesh Sharma was appointed as a Director was appointed as a Director on 01 Jul 2024 & has been associated with this company since 1 year 5 months . was completed.
Ajay Kumar Sharma was appointed as a Managing Director was appointed as a Managing Director on 01 Jul 2024 & has been associated with this company since 1 year 5 months . was recorded as a recent event.
V.R. Atharvaveda Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was recorded as a recent event.
The activity Vishesh Sharma was appointed as a Director was appointed as a Director on 03 Jul 2021 & has been associated with this company since 4 years 5 months . was completed.
The CIN of V.R. Atharvaveda Pharmaceuticals Private Limited is U24297UP2021PTC140940.
V.R. Atharvaveda Pharmaceuticals Private Limited is headquartered at H.N., 01 Vivekanand Nagar Aligarh Road Hathras, Hathras, Uttar Pradesh, 204101.
V.R. Atharvaveda Pharmaceuticals Private Limited was incorporated on 28 January 2021.
The current directors of V.R. Atharvaveda Pharmaceuticals Private Limited are
The primary industry of V.R. Atharvaveda Pharmaceuticals Private Limited is Healthcare.
V.R. Atharvaveda Pharmaceuticals Private Limited is unlisted.
The authorized capital of V.R. Atharvaveda Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
The compliance status of V.R. Atharvaveda Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX